News | Health & Safety
18 Dec 2017 0:55
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Days of Xmas
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     14 Dec: Research to help small babies grow in womb
     14 Dec: Google leads way on sex advice: study
     14 Dec: Tech upgrades set for mobile surgical bus
     12 Dec: Councillors unhappy at Karori campus sale
     12 Dec: Maori forced into mental health treatment
     12 Dec: Kiwi team makes Huntington's breakthrough
     12 Dec: Surgical mesh victims welcome restrictions
     Top Stories

    RUGBY RUGBY
    Australia bidding for 2027 Rugby World Cup More...


    BUSINESS BUSINESS
    Rural roads get $22.5m makeover More...



     Today's News

    Soccer:
    Sweet relief as Santalab snaps WSW drought 21:57

    Motoring:
    Bullets new NBL road kings 21:17

    International:
    Brisbane Roar v Melbourne Victory: A-League live scores, stats and commentary 20:57

    Soccer:
    City's McCormack cleared of ACL injury 20:47

    Basketball:
    Desperate Kings register rare NBL win 20:27

    Accident and Emergency:
    Ten injured in pile-up on SH1 20:07

    Soccer:
    Jets A-League captain urges caution 19:17

    Cricket:
    Wellington v Otago T20 game washed out 18:57

    Cricket:
    Uncommon Smith's peculiar habits 18:07

    Soccer:
    FFA to cull VAR personnel after more drama 17:57


     News Search






    Power Search


    © 2017 New Zealand City Ltd